2751609-45-5
Chemical Structure
Estrogen receptor antagonist 1
- CAS No.: 2751609-45-5
- Formula:C28H33F4N5
- Molecular Weight:515.59
IUPAC Name: (S)-5-(3-fluoropropyl)-N-(6-((1S,3R)-3-methyl-2-(2,2,2-trifluoroethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)pyridin-3-yl)-5-azaspiro[2.4]heptan-7-amine
InChIKey: YOOLNGDPKYLAAF-DETVKUJNSA-N
SMILES: FCCCN(C1)CC2(CC2)[C@@H]1NC3=CN=C([C@]4([H])C5=C(C[C@H](N4CC(F)(F)F)C)C6=CC=CC=C6N5)C=C3
Biological Activity: Estrogen receptor antagonist 1 is a selective estrogen receptor antagonist. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 1 has the potential for the research of breast cancer diseases (extracted from patent WO2021249533A1, compound 4)[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Estrogen receptor antagonist 1 | Estrogen receptor antagonist 1 is a selective estrogen receptor antagonist. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 1 has the potential for the research of breast cancer diseases (extracted from patent WO2021249533A1, compound 4). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
